Apollo Global Management Faces Legal Scrutiny Over Epstein Relationship Disclosures

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Apollo Global Management faces legal investigation over undisclosed Jeffrey Epstein business relationship, contradicting prior public statements and raising investor disclosure concerns.

Apollo Global Management Faces Legal Scrutiny Over Epstein Relationship Disclosures

The Rosen Law Firm has initiated an investigation into Apollo Global Management, Inc. (NYSE: APO) following revelations regarding the firm's undisclosed business relationship with Jeffrey Epstein. According to a Financial Times investigation, senior Apollo executives, including Chief Executive Officer Marc Rowan, engaged with Epstein on tax-related matters throughout the 2010s. This disclosure contradicts Apollo's prior public statements asserting that the firm had not conducted business with Epstein.

The investigation centers on whether Apollo's previous representations regarding its relationship with Epstein constitute materially misleading statements to investors. The firm's failure to disclose these consulting interactions raises questions about the accuracy and completeness of information provided to shareholders during the relevant period.

Market reaction to the disclosure has been pronounced, with APO stock declining 1 percent on February 2, 2026, followed by a more significant 4.76 percent drop on February 3, 2026. The Rosen Law Firm is encouraging investors who have sustained losses in Apollo Global Management securities to contact the firm regarding potential shareholder rights and legal remedies.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 24

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON